Albers Jeffrey W.

CIK 00016384744 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001638474

Recent Transactions

50 trades

Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-08-07$10.39/sh+5,000→ 5,000 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-08-07$104.38/sh−8,000→ 19,360 total
Exercise/Conversion
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-08-07−5,000→ 45,000 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-08-07$104.68/sh−10,000→ 9,360 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-08-07$104.47/sh−5,000→ 0 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-06-24+6,068→ 6,068 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-05-27+8,026→ 8,026 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$90.30/sh−2,252→ 0 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$89.32/sh−2,748→ 2,252 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-12-08−5,000→ 7,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-08$14.18/sh+5,000→ 5,000 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-13$59.19/sh−5,000→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-10-13$10.34/sh+5,000→ 5,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-10-13−5,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−5,777→ 144,755 total
Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−144,755→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,570→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−92,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−15,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−170,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−110,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−80,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−90,000→ 0 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 total
Award
Blueprint Medicines Corp
Common Stock
2025-06-18$128.12/sh+3,902→ 150,532 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-03−6,349→ 5,000 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$49.00/sh−6,349→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$10.34/sh+6,349→ 6,349 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2025-05-29+25,000→ 25,000 total
Sale
Blueprint Medicines Corp
Common Stock
2025-05-27$101.02/sh−4,350→ 147,280 total
Sale
Blueprint Medicines Corp
Common Stock
2025-05-27$101.93/sh−650→ 146,630 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2025-05-27$36.05/sh+5,000→ 151,630 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-05-27−5,000→ 92,500 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-12$88.37/sh−1,800→ 152,396 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-12$87.62/sh−5,700→ 154,196 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2025-03-12$36.05/sh+7,500→ 159,896 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-03-12−7,500→ 97,500 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-05$88.80/sh−5,766→ 146,630 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-01-21−10,000→ 105,000 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2025-01-21$36.05/sh+10,000→ 167,557 total
Sale
Blueprint Medicines Corp
Common Stock
2025-01-21$109.11/sh−7,561→ 159,996 total
Sale
Blueprint Medicines Corp
Common Stock
2025-01-21$109.92/sh−7,400→ 152,596 total
Sale
Blueprint Medicines Corp
Common Stock
2025-01-21$110.61/sh−200→ 152,396 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-01-13−5,000→ 115,000 total
Sale
Blueprint Medicines Corp
Common Stock
2025-01-13$102.28/sh−5,000→ 157,557 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2025-01-13$36.05/sh+5,000→ 162,557 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-12-19$36.05/sh−15,000→ 120,000 total
Sale
Blueprint Medicines Corp
Common Stock
2024-12-19$91.96/sh−2,100→ 157,557 total
Sale
Blueprint Medicines Corp
Common Stock
2024-12-19$91.15/sh−3,800→ 159,657 total

Companies

Recent Filings

Address

221 CRESCENT STREET, BUILDING 23, SUITE 105

WALTHAM, MA, 02453

View on SEC.gov